BSPM
Biostar Pharmaceuticals, Inc.
BSPM
BSPM
Delisted
BSPM was delisted on the 18th of September, 2018.
6 hedge funds and large institutions have $305K invested in Biostar Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$1K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Acadian Asset Management
Boston,
Massachusetts
| $239K | 107,196 | +6,001 | +6% |
|
2
Barclays
London,
United Kingdom
| $41K | 18,300 | +18,300 | New |
|
3
Morgan Stanley
New York
| $9K | 3,950 | +3,926 | +16,358% |
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $8K | 3,500 | +3,100 | +775% |
|
|
IA
5
IFP Advisors
Tampa,
Florida
| $7K | 3,250 | +3,250 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $1K | 297 | -689 | -70% |
|